# Roku, Inc: financial statements, quarterly ROKU · Nasdaq · CIK 1428439 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/roku.md) · [Financials](/companies/roku/financials.md) · [Filings](/companies/roku/filings.md) · [Insiders](/companies/roku/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/roku/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [912](/filings/0001428439-24-000042.md) | [984 d](/filings/0001628280-26-008114.md) | [881](/filings/0001428439-25-000017.md) | [968](/filings/0001428439-25-000040.md) | [1,062](/filings/0001628280-25-047808.md) | [1,201 d](/filings/0001628280-26-008114.md) | [1,021](/filings/0001628280-26-029310.md) | [1,111](/filings/0001628280-26-054335.md) | [1,211](/filings/0001628280-25-047808.md) | [1,395 d](/filings/0001628280-26-008114.md) | [1,249](/filings/0001628280-26-029310.md) | [1,355](/filings/0001628280-26-054335.md) | | Cost of revenue | $m | [543](/filings/0001428439-24-000042.md) | [547 d](/filings/0001628280-26-008114.md) | [493](/filings/0001428439-25-000017.md) | [543](/filings/0001428439-25-000040.md) | [582](/filings/0001628280-25-047808.md) | [688 d](/filings/0001628280-26-008114.md) | [576](/filings/0001628280-26-029310.md) | [613](/filings/0001628280-26-054335.md) | [686](/filings/0001628280-25-047808.md) | [788 d](/filings/0001628280-26-008114.md) | [684](/filings/0001628280-26-029310.md) | [681](/filings/0001628280-26-054335.md) | | Gross profit | $m | [369](/filings/0001428439-24-000042.md) | [438 d](/filings/0001628280-26-008114.md) | [388](/filings/0001428439-25-000017.md) | [425](/filings/0001428439-25-000040.md) | [480](/filings/0001628280-25-047808.md) | [513 d](/filings/0001628280-26-008114.md) | [445](/filings/0001628280-26-029310.md) | [498](/filings/0001628280-26-054335.md) | [525](/filings/0001628280-25-047808.md) | [607 d](/filings/0001628280-26-008114.md) | [565](/filings/0001628280-26-029310.md) | [674](/filings/0001628280-26-054335.md) | | Research and development | $m | [282](/filings/0001428439-24-000042.md) | [184 d](/filings/0001628280-26-008114.md) | [180](/filings/0001428439-25-000017.md) | [175](/filings/0001428439-25-000040.md) | [179](/filings/0001628280-25-047808.md) | [185 d](/filings/0001628280-26-008114.md) | [185](/filings/0001628280-26-029310.md) | [178](/filings/0001628280-26-054335.md) | [182](/filings/0001628280-25-047808.md) | [185 d](/filings/0001628280-26-008114.md) | [189](/filings/0001628280-26-029310.md) | [180](/filings/0001628280-26-054335.md) | | Operating income | $m | [(350)](/filings/0001428439-24-000042.md) | [(104) d](/filings/0001628280-26-008114.md) | [(72.0)](/filings/0001428439-25-000017.md) | [(71.2)](/filings/0001428439-25-000040.md) | [(35.8)](/filings/0001628280-25-047808.md) | [(39.1) d](/filings/0001628280-26-008114.md) | [(57.7)](/filings/0001628280-26-029310.md) | [(23.3)](/filings/0001628280-26-054335.md) | [9.5](/filings/0001628280-25-047808.md) | [66.0 d](/filings/0001628280-26-008114.md) | [51.8](/filings/0001628280-26-029310.md) | [146](/filings/0001628280-26-054335.md) | | Interest expense | $m | not reported | not reported | [0.0](/filings/0001428439-25-000017.md) | [0.0](/filings/0001428439-25-000040.md) | [0.0](/filings/0001628280-25-047808.md) | [0.4 d](/filings/0001628280-26-008114.md) | [0.4](/filings/0001628280-26-029310.md) | [0.5](/filings/0001628280-26-054335.md) | [0.5](/filings/0001628280-25-047808.md) | [0.6 d](/filings/0001628280-26-008114.md) | [0.6](/filings/0001628280-26-029310.md) | [0.5](/filings/0001628280-26-054335.md) | | Income tax | $m | [3.2](/filings/0001428439-24-000042.md) | [1.8 d](/filings/0001628280-26-008114.md) | [4.8](/filings/0001428439-25-000017.md) | [(9.2)](/filings/0001428439-25-000040.md) | [4.1](/filings/0001628280-25-047808.md) | [9.7 d](/filings/0001628280-26-008114.md) | [(13.1)](/filings/0001628280-26-029310.md) | [(5.8)](/filings/0001628280-26-054335.md) | [13.2](/filings/0001628280-25-047808.md) | [11.2 d](/filings/0001628280-26-008114.md) | [2.9](/filings/0001628280-26-029310.md) | [5.2](/filings/0001628280-26-054335.md) | | Net income | $m | [(330)](/filings/0001428439-24-000042.md) | [(78.3) d](/filings/0001628280-26-008114.md) | [(50.9)](/filings/0001428439-25-000017.md) | [(34.0)](/filings/0001428439-25-000040.md) | [(9.0)](/filings/0001628280-25-047808.md) | [(35.5) d](/filings/0001628280-26-008114.md) | [(27.4)](/filings/0001628280-26-029310.md) | [10.5](/filings/0001628280-26-054335.md) | [24.8](/filings/0001628280-25-047808.md) | [80.5 d](/filings/0001628280-26-008114.md) | [85.7](/filings/0001628280-26-029310.md) | [164](/filings/0001628280-26-054335.md) | | Diluted EPS | $ per share | [(2.33)](/filings/0001428439-24-000042.md) | not reported | [(0.35)](/filings/0001428439-25-000017.md) | [(0.24)](/filings/0001428439-25-000040.md) | [(0.06)](/filings/0001628280-25-047808.md) | not reported | [(0.19)](/filings/0001628280-26-029310.md) | [0.07](/filings/0001628280-26-054335.md) | [0.16](/filings/0001628280-25-047808.md) | not reported | [0.57](/filings/0001628280-26-029310.md) | [1.08](/filings/0001628280-26-054335.md) | | Basic EPS | $ per share | [(2.33)](/filings/0001428439-24-000042.md) | not reported | [(0.35)](/filings/0001428439-25-000017.md) | [(0.24)](/filings/0001428439-25-000040.md) | [(0.06)](/filings/0001628280-25-047808.md) | not reported | [(0.19)](/filings/0001628280-26-029310.md) | [0.07](/filings/0001628280-26-054335.md) | [0.17](/filings/0001628280-25-047808.md) | not reported | [0.58](/filings/0001628280-26-029310.md) | [1.11](/filings/0001628280-26-054335.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [2,003](/filings/0001428439-24-000042.md) | [2,026](/filings/0001628280-26-008114.md) | [2,056](/filings/0001428439-25-000017.md) | [2,058](/filings/0001428439-25-000040.md) | [2,127](/filings/0001628280-25-047808.md) | [2,160](/filings/0001628280-26-008114.md) | [2,256](/filings/0001628280-26-029310.md) | [2,253](/filings/0001428439-25-000040.md) | [1,575](/filings/0001628280-25-047808.md) | [1,587](/filings/0001628280-26-054335.md) | [1,650](/filings/0001628280-26-029310.md) | [2,002](/filings/0001628280-26-054335.md) | | Current assets | $m | [2,971](/filings/0001428439-23-000041.md) | [3,073](/filings/0001428439-25-000013.md) | [2,996](/filings/0001428439-24-000019.md) | [2,977](/filings/0001428439-24-000034.md) | [3,186](/filings/0001428439-24-000042.md) | [3,234](/filings/0001628280-26-008114.md) | [3,147](/filings/0001428439-25-000017.md) | [3,158](/filings/0001428439-25-000040.md) | [3,329](/filings/0001628280-25-047808.md) | [3,402](/filings/0001628280-26-054335.md) | [3,371](/filings/0001628280-26-029310.md) | [3,606](/filings/0001628280-26-054335.md) | | Total assets | $m | [4,191](/filings/0001428439-23-000041.md) | [4,262](/filings/0001428439-25-000013.md) | [4,152](/filings/0001428439-24-000019.md) | [4,104](/filings/0001428439-24-000034.md) | [4,303](/filings/0001428439-24-000042.md) | [4,304](/filings/0001628280-26-008114.md) | [4,180](/filings/0001428439-25-000017.md) | [4,282](/filings/0001428439-25-000040.md) | [4,397](/filings/0001628280-25-047808.md) | [4,433](/filings/0001628280-26-054335.md) | [4,353](/filings/0001628280-26-029310.md) | [4,573](/filings/0001628280-26-054335.md) | | Current liabilities | $m | [1,208](/filings/0001428439-23-000041.md) | [1,276](/filings/0001428439-25-000013.md) | [1,160](/filings/0001428439-24-000019.md) | [1,097](/filings/0001428439-24-000034.md) | [1,241](/filings/0001428439-24-000042.md) | [1,233](/filings/0001628280-26-008114.md) | [1,099](/filings/0001428439-25-000017.md) | [1,108](/filings/0001428439-25-000040.md) | [1,215](/filings/0001628280-25-047808.md) | [1,238](/filings/0001628280-26-054335.md) | [1,158](/filings/0001628280-26-029310.md) | [1,258](/filings/0001628280-26-054335.md) | | Total liabilities | $m | [1,883](/filings/0001428439-23-000041.md) | [1,935](/filings/0001428439-25-000013.md) | [1,796](/filings/0001428439-24-000019.md) | [1,714](/filings/0001428439-24-000034.md) | [1,843](/filings/0001428439-24-000042.md) | [1,811](/filings/0001628280-26-008114.md) | [1,654](/filings/0001428439-25-000017.md) | [1,691](/filings/0001428439-25-000040.md) | [1,772](/filings/0001628280-25-047808.md) | [1,776](/filings/0001628280-26-054335.md) | [1,682](/filings/0001628280-26-029310.md) | [1,749](/filings/0001628280-26-054335.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Current portion of debt | $m | [0.0](/filings/0001428439-23-000041.md) | [0.0](/filings/0001428439-24-000011.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [2,307](/filings/0001428439-24-000042.md) | [2,326](/filings/0001628280-26-008114.md) | [2,356](/filings/0001428439-25-000040.md) | [2,391](/filings/0001628280-25-047808.md) | [2,461](/filings/0001628280-25-047808.md) | [2,493](/filings/0001628280-26-054335.md) | [2,526](/filings/0001628280-26-054335.md) | [2,591](/filings/0001628280-26-054335.md) | [2,625](/filings/0001628280-25-047808.md) | [2,658](/filings/0001628280-26-054335.md) | [2,671](/filings/0001628280-26-054335.md) | [2,823](/filings/0001628280-26-054335.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Current portion of debt: us-gaap:LongTermDebtCurrent - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [246 d](/filings/0001428439-24-000042.md) | [16.3 d](/filings/0001628280-26-008114.md) | [46.7](/filings/0001428439-25-000017.md) | [23.4 d](/filings/0001428439-25-000040.md) | [68.7 d](/filings/0001628280-25-047808.md) | [79.3 d](/filings/0001628280-26-008114.md) | [139](/filings/0001628280-26-029310.md) | [110 d](/filings/0001628280-26-054335.md) | [128 d](/filings/0001628280-25-047808.md) | [108 d](/filings/0001628280-26-008114.md) | [199](/filings/0001628280-26-029310.md) | [285 d](/filings/0001628280-26-054335.md) | | Capital expenditure | $m | [6.8 d](/filings/0001428439-24-000042.md) | [3.5 d](/filings/0001628280-26-008114.md) | [0.7](/filings/0001428439-25-000017.md) | [0.9 d](/filings/0001428439-25-000040.md) | [1.1 d](/filings/0001628280-25-047808.md) | [2.5 d](/filings/0001628280-26-008114.md) | [1.9](/filings/0001628280-26-029310.md) | [1.1 d](/filings/0001628280-26-054335.md) | [1.1 d](/filings/0001628280-25-047808.md) | [1.1 d](/filings/0001628280-26-008114.md) | [3.1](/filings/0001628280-26-029310.md) | [3.8 d](/filings/0001628280-26-054335.md) | | Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001628280-26-008114.md) | [0.0](/filings/0001628280-26-029310.md) | [0.0 d](/filings/0001628280-26-054335.md) | [50.0 d](/filings/0001628280-25-047808.md) | [100.0 d](/filings/0001628280-26-008114.md) | [100](/filings/0001628280-26-029310.md) | [62.7 d](/filings/0001628280-26-054335.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [139](/filings/0001428439-23-000041.md) | [140](/filings/0001428439-24-000019.md) | [141](/filings/0001428439-24-000034.md) | [142](/filings/0001428439-24-000042.md) | [144](/filings/0001428439-25-000017.md) | [144](/filings/0001428439-25-000040.md) | [145](/filings/0001628280-25-047808.md) | [146](/filings/0001628280-26-029310.md) | [150](/filings/0001628280-26-054335.md) | [152](/filings/0001628280-25-047808.md) | [151](/filings/0001628280-26-029310.md) | [152](/filings/0001628280-26-054335.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.